The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in puerto rico

Active Project Grant Awarded Last action

Award ID
R01CA282424
Recipient
Awarding agency
Obligated
$2,411,311

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date 63% complete
Place of performance
Puerto Rico

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Cervical cancer incidence is increasing dramatically (2.5% per year) in puerto rico (PR), with increased occurrence of regional (1.7% per year) and distant (4.7% per year) stage cancer, which reflects a real increase and indicates missed screening opportunities. Unfortunately, 80% of cervical cancer cases diagnosed in PR occur among low-income women covered by medicaid or medicare, who also have a 70% greater likelihood of being diagnosed with cervical cancer. Cervical cancer screening uptake continues to decline in PR, particularly among low-income medicaid enrollees, mainly seen by government clinics. Barriers to cervical cancer screening in PR are mainly due to personal (lack of transportation, obesity-related embarrassment) and environmental (repeated disaster events that hampered screening uptake and made recovery slow) factors. The absence of evidence on the effectiveness, cost-effectiveness, and budget impact of patient navigators has limited its adoption among government clinics in this US territory. Multicomponent interventions that can address common screening barriers and improve screening participation in clinic-based settings or avert the need for a clinical-based visit could help improve screening uptake and follow-up care. Our preliminary work suggests the feasibility and acceptability of HPV self-sampling in PR. We now propose a hybrid type 1 effectiveness-implementation study using a four-arm multi-site randomized controlled trial (RCT) conducted within government obgyn clinics in PR. We will assess the effectiveness of patient reminders plus patient navigation and HPV self-collection (individually and in combination) compared to patient reminders alone in increasing cervical cancer screening, timely colposcopy, and cervical precancer treatment (aim 1). The secondary aim will evaluate key implementation outcomes, including patient and provider receptivity, reach, level of implementation and fidelity, and sustainment intentions. We will then develop an open-cohort microsimulation model to evaluate the population impact, cost-effectiveness, and budget impact of alternative strategies (aim 2) to inform their potential applicability at delivery organization, community, and territory levels. This study will provide much-needed knowledge that is necessary to successfully facilitate the adoption and sustained integration of optimal strategies that will improve cervical cancer screening participation and reduce magnifying disparities in puerto rico.

Transactions

Action Obligated Date
Amendment $44,843
Amendment $560,185
Amendment $0
Amendment $0
Amendment $50,587
Amendment $542,687
Amendment $50,587
Amendment $542,687
Amendment $26,422
Amendment $26,422
Original award $566,891
Show all 11

Quick answers

Who received award R01CA282424?

R01CA282424 was awarded to Centro Comprensivo De Cancer De La Universidad De Puerto Rico by National Cancer Institute (National Institutes of Health) on September 19, 2023.

How much is award R01CA282424 worth?

$2,411,311 has been obligated on R01CA282424.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login